View in EDS

SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.

Saved in:

Bibliographic Details
Title:	SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.
Authors:	Saksena NK; Victoria University, Footscray Campus, Melbourne, VIC. Australia. Electronic address: nitin.saksena@aegros.com.au., Reddy SB; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Miranda-Saksena M; Westmead Institute for Medical Research, Sydney. Australia. Electronic address: monica.saksena@sydney.edu.au., Cardoso THS; OMICS Centre of Excellence, G42 Healthcare, Mazdar City, Abu Dhabi, United Arab Emirates. Electronic address: Thyago.cardoso@g42.ai., Silva EMA; Science Division, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Ferreira JC; Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates. Electronic address: jcf10@nyu.edu., Rabeh WM; Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates. Electronic address: wael.rabeh@nyu.edu.
Source:	Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2023 Dec; Vol. 1869 (8), pp. 166836. Date of Electronic Publication: 2023 Aug 05.
Publication Type:	Review; Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-260X (Electronic) Linking ISSN: 09254439 NLM ISO Abbreviation: Biochim Biophys Acta Mol Basis Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1879-260X
DOI:	10.1016/j.bbadis.2023.166836